All In MedTech

Device Trial Radar · NCT00838045

Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens

A Prospective, Multi-Center Clinical Investigation to Evaluate the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL (Model MI60) Intraocular Lens

Last checked: Nov 20, 2026Latest source record: Dec 9, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

125

Actual

Start

Sep 2006

Primary completion

Apr 2008

Study completion Sep 2008

Sponsor

Lead sponsor
Bausch & Lomb IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Feb 6, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 50 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is to evaluate the safety and effectiveness of the Bausch \& Lomb Akreos TL (thin lens) intraocular lens (IOL) following implantation in adults requiring cataract surgery.

Conditions

  • Cataract
  • Aphakia

Interventions

  • The Bausch & Lomb Akreos TL IOL (MI60) posterior chamber IOLDevice

    Surgery to implant the Bausch \& Lomb Akreos TL Intraocular Lens will be performed using standard microsurgical techniques following cataract surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Bast Corrected Visual AcuityTime frame: 24 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Klinikum der J.W. Goethe-Universität

    Frankfurt, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.